Original Articles
Vol. 66 No. 4 (2017)
https://doi.org/10.4081/mem.2017.505
Il dibattito in Bioetica - I nuovi farmaci per l'HCV: una possibile "lezione metodologica" / The debate in Bioethics. The new drugs for HCV: a possible "methodological lesson"
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 11 October 2017
Accepted: 11 October 2017
Published: 11 October 2017
Accepted: 11 October 2017
Published: 11 October 2017
1018
Views
20
Downloads
Downloads
Download data is not yet available.
How to Cite
Il dibattito in Bioetica - I nuovi farmaci per l’HCV: una possibile "lezione metodologica" / The debate in Bioethics. The new drugs for HCV: a possible "methodological lesson". (2017). Medicina E Morale, 66(4), 533-537. https://doi.org/10.4081/mem.2017.505
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.